DocetaxelLiver toxicity following an off-label use of docetaxel for metastatic hormone-naive prostate cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1716卷 / 1期

关键词：

D O I：

10.1007/s40278-018-50920-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：122 / 122

相关论文

共 50 条

[31] FelbamateNeutropenia following off-label use: case report
Reactions Weekly, 2020, 1803 (1) : 111 - 111
[32] MethylprednisoloneFungaemia following an off-label use: case report
Reactions Weekly, 2022, 1899 (1) : 243 - 243
[33] SirolimusPneumonia following off-label use: case report
Reactions Weekly, 2020, 1800 (1) : 269 - 269
[34] ClonazepamMisidentification following off-label use: case report
Reactions Weekly, 2022, 1926 (1) : 171 - 171
[35] RituximabAgranulocytosis following off-label use: case report
Reactions Weekly, 2018, 1712 (1) : 482 - 482
[36] InsulinHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 204 - 204
[37] GalcanezumabConstipation following off-label use: case report
Reactions Weekly, 2025, 2046 (1) : 169 - 169
[38] BevacizumabCataract following off-label use: case report
Reactions Weekly, 2019, 1747 (1) : 63 - 63
[39] SirolimusNeutropenia following off-label use: case report
Reactions Weekly, 2023, 1960 (1) : 394 - 394
[40] RisperidonePancreatitis following off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 378 - 378

← 1 2 3 4 5 →